Science Explorer Back to mapMap
Discussion

PreludeDx (United States)

Research works
14
▲ 93% vs 2018-21
Citations
85
6.2 per fractional work
Top-10% rate
11.0%
all institutions 10.0%
Open access
47%
world 40%
International
44%
world 18%

Not ranked overall: PreludeDx (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does PreludeDx (United States) work in?

In all years, 46% of research at PreludeDx (United States) is in Life Sciences, 45% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (45%), Medicine (45%), Arts and Humanities (2%). It does 1.8× the world's share of Life Sciences.

Life Sciences: 6 fractional works · 46.1% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 45.3% of its workCancer Research: 4 fractional works · 27.7% of its workMolecular Biology: 1 fractional works · 10.3% of its workGenetics: 1 fractional works · 7.3% of its workImmunology and Microbiology: 0 fractional works · 0.8% of its workImmunology: 0 fractional works · 0.8% of its workHealth Sciences: 6 fractional works · 45.3% of its workMedicine: 6 fractional works · 45.3% of its workOncology: 2 fractional works · 15.3% of its workPathology and Forensic Medicine: 2 fractional works · 11.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 6.5% of its workSurgery: 1 fractional works · 4.3% of its workPulmonary and Respiratory Medicine: 0 fractional works · 2.9% of its workDermatology: 0 fractional works · 1.2% of its workEpidemiology: 0 fractional works · 1.2% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.7% of its workReproductive Medicine: 0 fractional works · 0.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.4% of its workSocial Sciences: 1 fractional works · 5.1% of its workArts and Humanities: 0 fractional works · 2.4% of its workLanguage and Linguistics: 0 fractional works · 1.2% of its workLiterature and Literary Theory: 0 fractional works · 1.2% of its workSocial Sciences: 0 fractional works · 2.2% of its workEducation: 0 fractional works · 1.7% of its workSafety Research: 0 fractional works · 0.5% of its workPsychology: 0 fractional works · 0.5% of its workClinical Psychology: 0 fractional works · 0.5% of its workPhysical Sciences: 0 fractional works · 3.4% of its workEngineering: 0 fractional works · 1.8% of its workBiomedical Engineering: 0 fractional works · 1.8% of its workMathematics: 0 fractional works · 1.0% of its workStatistics and Probability: 0 fractional works · 1.0% of its workPhysics and Astronomy: 0 fractional works · 0.6% of its workRadiation: 0 fractional works · 0.6% of its workALL ITS WORKPreludeDx (UnitedStates)14fractional works, all years
Life Sciences46%Physical Sciences3%Health Sciences45%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology645.3%
    2. Immunology and Microbiology00.8%
    1. Medicine645.3%
    1. Arts and Humanities02.4%
    2. Social Sciences02.2%
    3. Psychology00.5%
    1. Engineering01.8%
    2. Mathematics01.0%
    3. Physics and Astronomy00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 9.59× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 1.18× its world share, 0 worksImmunology and Micro…Engineering: 0.18× its world share, 0 worksEngineeringMathematics: 1.26× its world share, 0 worksMathematicsPhysics and Astronomy: 0.41× its world share, 0 worksPhysics and AstronomyMedicine: 2.21× its world share, 4 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 9.6×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology9.59×5 works
  2. Medicine2.21×4 works
  3. Mathematics1.26×0 works
  4. Immunology and Microbiology1.18×0 works
  5. Physics and Astronomy0.41×0 works
  6. Engineering0.18×0 works

Who are the top researchers at PreludeDx (United States)?

Ranked on the quality score, Troy M. Bremer and Jess Savala lead among researchers whose main affiliation is PreludeDx (United States).

  1. 1 Troy M. Bremer United States · #1,165,405 worldwide 1.3k citations · 116 works
  2. 2 Jess Savala United States · #1,504,069 worldwide 257 citations · 46 works
All ranked researchers at PreludeDx (United States)

What are the most cited papers from PreludeDx (United States)?

The most cited paper from PreludeDx (United States) is "A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk" (Troy M. Bremer, Pat W. Whitworth, Rakesh P. Patel et al., 2018), with 128 citations. Next come "The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery" (58) and "Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)" (55).

Most cited papers
#PaperReleasedCitations
1 A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk Troy M. Bremer, Pat W. Whitworth, Rakesh P. Patel et al. · Clinical Cancer Research 27 Jul 2018 128
2 The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery Chirag Shah et al. · Annals of Surgical Oncology Open access 5 Apr 2021 58
3 Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS) Fredrik Wärnberg, Per Karlsson, Erik C. Holmberg et al. · Cancers Open access 3 Dec 2021 55
4 A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy Frank A. Vicini, G. Bruce Mann, Chirag Shah et al. · International Journal of Radiation Oncology*Biology*Physics Open access 15 Sep 2022 36
5 Quantitative comparison of immunohistochemical HER2 ‐low detection in an interlaboratory study Maaike Anna Hempenius, Maran A Eenkhoorn, Henrik Høeg et al. · Histopathology Open access 29 Jul 2024 28
All 39 most cited papers, with filters and sorting

Which research topics does PreludeDx (United States) publish most on?

By volume in 2022-now: Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, BRCA gene mutations in cancer and Cancer Genomics and Diagnostics.

  1. 1 Breast Cancer Treatment Studies Cancer Research 2 works
  2. 2 Breast Lesions and Carcinomas Pathology and Forensic Medicine 1 works
  3. 3 BRCA gene mutations in cancer Genetics 1 works
  4. 4 Cancer Genomics and Diagnostics Cancer Research 1 works
  5. 5 HER2/EGFR in Cancer Research Oncology 0 works
  6. 6 Genomics and Chromatin Dynamics Molecular Biology 0 works
  7. 7 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
  8. 8 Protein Degradation and Inhibitors Molecular Biology 0 works
  9. 9 Advances in Oncology and Radiotherapy Radiology, Nuclear Medicine and Imaging 0 works
  10. 10 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.4%not open52.6%

World: 40% of research is openly available.

with international co-authors44.1%domestic only55.9%

World: 18% is written across borders.

How has PreludeDx (United States)'s research output changed?

Output in 2022-2025 was 93% higher than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is PreludeDx (United States) as a percentage of every work published that year, 0.000043% in 2024.

still counting0.000025%0.000050%0.000075%PreludeDx (United States)0.000015% in 20252020

Fractional works of PreludeDx (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Laguna Hills

All research institutions in Laguna Hills

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about PreludeDx (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.